作者: Mineo Matsumoto , Shinichi Komatsu
关键词:
摘要: 1 Review Division, Pharmaceuticals and Medical Devices Agency (PMDA), Kasumigaseki 3-3-2, Chiyoda-ku, Tokyo 100-0013, Japan 2 Research Development Department, POC Clinical Inc. Taishidou 4-11, Setagaya-ku, 154-0004, 3 Pathology The Chemo-SeroTherapeutic Institute, Kyokushi Kawabe 1314-1, Kikuchi-shi, Kumamoto 869-1298, 4 Vaccine Laboratories, Kitasato Daiichi Sankyo Co. Ltd., Kita-Kasai 1-16-13, Edogawa-ku, 134-8630, 5 Chugai Pharmaceutical Komakado, 1-135, Gotemba, Shizuoka 412-8513,